Chng WJ - Search Results

1

Lipid profiles and outcomes of patients with prior cancer and subsequent myocardial infarction or stroke.

Koo CY, Zheng H, Tan LL, Foo LL, Seet R, Chong JH, Hausenloy DJ, Chng WJ, Richards AM, Lee CH, Chan MY. Koo CY, et al. Among authors: chng wj. Sci Rep. 2021 Oct 27;11(1):21167. doi: 10.1038/s41598-021-00666-z. Sci Rep. 2021. PMID: 34707180 Free PMC article.

2

Prior Cancer Is Associated with Lower Atherosclerotic Cardiovascular Disease Risk at First Acute Myocardial Infarction.

Koo CY, Zheng H, Tan LL, Foo LL, Hausenloy DJ, Chng WJ, Lee SC, Richards AM, Ling LH, Lim SL, Lee CH, Chan MY. Koo CY, et al. Among authors: chng wj. Biomedicines. 2022 Oct 23;10(11):2681. doi: 10.3390/biomedicines10112681. Biomedicines. 2022. PMID: 36359201 Free PMC article.

3

Super-Enhancers and Broad H3K4me3 Domains Form Complex Gene Regulatory Circuits Involving Chromatin Interactions.

Cao F, Fang Y, Tan HK, Goh Y, Choy JYH, Koh BTH, Hao Tan J, Bertin N, Ramadass A, Hunter E, Green J, Salter M, Akoulitchev A, Wang W, Chng WJ, Tenen DG, Fullwood MJ. Cao F, et al. Among authors: chng wj. Sci Rep. 2017 May 19;7(1):2186. doi: 10.1038/s41598-017-02257-3. Sci Rep. 2017. PMID: 28526829 Free PMC article.

4

Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital.

Poon LM, Jin J, Chee YL, Ding Y, Lee YM, Chng WJ, Chai LY, Tan LK, Hsu LY. Poon LM, et al. Among authors: chng wj. Singapore Med J. 2012 Nov;53(11):720-5. Singapore Med J. 2012. PMID: 23192498 Free article.

5

Super-enhancers: critical roles and therapeutic targets in hematologic malignancies.

Jia Y, Chng WJ, Zhou J. Jia Y, et al. Among authors: chng wj. J Hematol Oncol. 2019 Jul 16;12(1):77. doi: 10.1186/s13045-019-0757-y. J Hematol Oncol. 2019. PMID: 31311566 Free PMC article. Review.

6

Daratumumab-based induction therapy for multiple myeloma: A systematic review and meta-analysis.

Chong LL, Soon YY, Soekojo CY, Ooi M, Chng WJ, de Mel S. Chong LL, et al. Among authors: chng wj. Crit Rev Oncol Hematol. 2021 Mar;159:103211. doi: 10.1016/j.critrevonc.2020.103211. Epub 2020 Dec 30. Crit Rev Oncol Hematol. 2021. PMID: 33387628 Review.

7

Risk Stratification in Multiple Myeloma.

Ooi MG, de Mel S, Chng WJ. Ooi MG, et al. Among authors: chng wj. Curr Hematol Malig Rep. 2016 Apr;11(2):137-47. doi: 10.1007/s11899-016-0307-4. Curr Hematol Malig Rep. 2016. PMID: 26883334 Review.

8

Clinical implications of DNMT3A mutations in a Southeast Asian cohort of acute myeloid leukaemia patients.

Tan M, Ng IKS, Chen Z, Ban K, Ng C, Chiu L, Seah E, Lin M, Tai BC, Yan B, Ng CH, Chng WJ. Tan M, et al. Among authors: chng wj. J Clin Pathol. 2017 Aug;70(8):669-676. doi: 10.1136/jclinpath-2016-204195. Epub 2017 Jan 18. J Clin Pathol. 2017. PMID: 28100593

9

Cancer in 2019 - Progress and Challenges - A Perspective.

Chng WJ. Chng WJ. Ann Acad Med Singap. 2019 Feb;48(2):45-47. Ann Acad Med Singap. 2019. PMID: 30926975 Free article. No abstract available.

10

Genomic characterization of functional high-risk multiple myeloma patients.

Soekojo CY, Chung TH, Furqan MS, Chng WJ. Soekojo CY, et al. Among authors: chng wj. Blood Cancer J. 2022 Jan 31;12(1):24. doi: 10.1038/s41408-021-00576-3. Blood Cancer J. 2022. PMID: 35102139 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

385 results

Search Page

Filters